RUNX1 and neoplasm: The results showed that Runx1 OE significantly promoted the tumor growth in vivo (Fig. 6B, C), while tumors in CT2A-shRunx1-implanted mice exhibited retarded growth rates (Fig. 6D, E), compared with the respective control mice.